Fenofibrate idd-p (insoluble drug delivery-micro particle) (DrugBank: Fenofibrate)
5 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
8 | Huntington disease | 0 |
79 | Homozygous familial hypercholesterolemia | 0 |
93 | Primary biliary cholangitis [Primary biliary cirrhosis (~Mar 2017)] | 1 |
94 | Primary sclerosing cholangitis | 0 |
265 | Lipodystrophy | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00575042 (ClinicalTrials.gov) | August 2007 | 13/12/2007 | Use of Fenofibrate for Primary Biliary Cirrhosis | Pilot Study of Fenofibrate for Primary Biliary Cirrhosis | Primary Biliary Cirrhosis | Drug: Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle) | University of Florida | The PBCers Organization;Shionogi Inc. | Completed | 21 Years | 75 Years | All | 20 | Phase 2 | United States |